The evaluation of the HIV/AIDS Drug Access Initiatives in Côte DʼIvoire, Senegal and Uganda
- 1 July 2003
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in AIDS
- Vol. 17, S1-S4
- https://doi.org/10.1097/00002030-200317003-00001
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Treating HIV in Resource-Poor SettingsPublished by American Medical Association (AMA) ,2002
- CROI meeting, SeattleAIDS, 2002
- The Senegalese government's highly active antiretroviral therapy initiative: an 18-month follow-up studyAIDS, 2002
- Assessment of a pilot antiretroviral drug therapy programme in Uganda: patients' response, survival, and drug resistanceThe Lancet, 2002
- Preventing antiretroviral anarchy in sub-Saharan AfricaThe Lancet, 2001
- A new global commitment to disease control in AfricaNature Medicine, 2001
- Breaking the silence: setting realistic priorities for AIDS control in less-developed countriesThe Lancet, 2000
- Scaling Up HIV/AIDS Programs to National CoverageScience, 2000
- Public Health Implications of Antiretroviral Therapy and HIV Drug ResistanceJAMA, 1998
- Implications of HIV treatment advances for behavioral research on AIDS: Protease inhibitors and new challenges in HIV secondary prevention.Health Psychology, 1998